MONIQUE BLANCHARD: Open Payments
NPI 1649277047 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 48 payments from 18 companies in 2025. Trend: 2023 $1,041 · 2024 $1,173 · 2025 $1,281
Food & beverage: $1,186Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $238 |
| Amgen Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 4 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Janssen Biotech, Inc. | 3 | $80 |
| Incyte Corporation | 3 | $66 |
| UCB, Inc. | 2 | $59 |
| LEO Pharma Inc. | 3 | $50 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, EBGLYSS, COSENTYX, TREMFYA, RINVOQ, OPZELURA.
Industry payments across LA — which companies pay providers there.
